v.231201
Showing details for project SYSMHC00064
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
|---|---|---|---|---|---|
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
| SYSMHC00064_CLL_DFCI-5283 | 5 | Human | HLA-A01:01,HLA-A02:01,HLA-B07:02,HLA-B08:01,HLA-C07:01,HLA-C07:02 | ||
| SYSMHC00064_CLL_DFCI-5328 | 1 | Human | HLA-A02:06,HLA-A24:02,HLA-B08:01,HLA-B51:01,HLA-C07:02,HLA-C14:02 | ||
| SYSMHC00064_CLL_DFCI-5341 | 2 | Human | HLA-A03:01,HLA-A31:01,HLA-B14:02,HLA-B35:02,HLA-C04:01,HLA-C08:02 | ||
| SYSMHC00064_CP-594_v1 | 4 | Human | HLA-A02:01,HLA-A24:02,HLA-B35:03,HLA-B40:02,HLA-C05:01,HLA-C12:03 | ||
| SYSMHC00064_GBM_H4198_BT187 | 4 | Human | HLA-A01:01,HLA-A32:01,HLA-B15:01,HLA-C03:03,HLA-C03:04 | ||
| SYSMHC00064_GBM_H4198_BT187_IFN | 4 | Human | HLA-A01:01,HLA-A32:01,HLA-B15:01,HLA-C03:03,HLA-C03:04 | ||
| SYSMHC00064_GBM_H4512_BT145 | 3 | Human | HLA-A01:01,HLA-A32:01,HLA-B13:02,HLA-B40:02,HLA-C02:02,HLA-C06:02 | ||
| SYSMHC00064_GBM_H4512_BT145_IFN | 3 | Human | HLA-A01:01,HLA-A32:01,HLA-B13:02,HLA-B40:02,HLA-C02:02,HLA-C06:02 | ||
| SYSMHC00064_GBM_Pat7 | 2 | Human | HLA-A24:02,HLA-A68:01,HLA-B35:02,HLA-B35:03,HLA-C04:01 | ||
| SYSMHC00064_GBM_Pat7_IFN | 2 | Human | HLA-A24:02,HLA-A68:01,HLA-B35:02,HLA-B35:03,HLA-C04:01 | ||
| SYSMHC00064_MEL_13240-002 | 4 | Human | HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B44:02,HLA-C05:01,HLA-C07:02 | ||
| SYSMHC00064_MEL_13240-005 | 2 | Human | HLA-A01:01,HLA-B38:01,HLA-B56:01,HLA-C01:02,HLA-C06:02 | ||
| SYSMHC00064_MEL_13240-005_IFN | 2 | Human | HLA-A01:01,HLA-B38:01,HLA-B56:01,HLA-C01:02,HLA-C06:02 | ||
| SYSMHC00064_MEL_13240-006 | 2 | Human | HLA-A02:01,HLA-A03:01,HLA-B27:05,HLA-B47:01,HLA-C01:02,HLA-C06:02 | ||
| SYSMHC00064_MEL_13240-006_IFN | 2 | Human | HLA-A02:01,HLA-A03:01,HLA-B27:05,HLA-B47:01,HLA-C01:02,HLA-C06:02 | ||
| SYSMHC00064_MEL_13240-015 | 4 | Human | HLA-A02:01,HLA-A02:02,HLA-B13:02,HLA-B40:02,HLA-C02:02,HLA-C06:02 | ||
| SYSMHC00064_MEL_13240-015_IFN | 2 | Human | HLA-A02:01,HLA-A02:02,HLA-B13:02,HLA-B40:02,HLA-C02:02,HLA-C06:02 | ||
| SYSMHC00064_RCC_Pat9 | 2 | Human | no allele | ||
| SYSMHC00064_RCC_Pat9_IFN | 2 | Human | no allele |
Detailed view of sample SYSMHC00064_CLL_DFCI-5283
| ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
| SYSMHC00064 | SYSMHC00064_CLL_DFCI-5283 | YJ20180319_SK_HLA_DFCI-5283_97_Tumor_CD19_1IPs_noAPD_R1_01.raw | Human | In vitro | Blood | suspension | Chronic lymphocytic leukemia | class I | HLA-A01:01,HLA-A02:01,HLA-B07:02,HLA-B08:01,HLA-C07:01,HLA-C07:02 | 35675780 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | HPLC | no | DDA | HCD | 1 | |||||
| SYSMHC00064 | SYSMHC00064_CLL_DFCI-5283 | YJ20180319_SK_HLA_DFCI-5283_08_CD19_1IPs_noAPD_R1_01.raw | Human | In vitro | Blood | suspension | Chronic lymphocytic leukemia | class I | HLA-A01:01,HLA-A02:01,HLA-B07:02,HLA-B08:01,HLA-C07:01,HLA-C07:02 | 35675780 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | HPLC | no | DDA | HCD | 2 | |||||
| SYSMHC00064 | SYSMHC00064_CLL_DFCI-5283 | YJ20180319_SK_HLA_DFCI-5283_08_CD19_1IPs_noAPD_R1_02.raw | Human | In vitro | Blood | suspension | Chronic lymphocytic leukemia | class I | HLA-A01:01,HLA-A02:01,HLA-B07:02,HLA-B08:01,HLA-C07:01,HLA-C07:02 | 35675780 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | HPLC | no | DDA | HCD | 3 | |||||
| SYSMHC00064 | SYSMHC00064_CLL_DFCI-5283 | G20141113_JGA_3rd_w632IP_HLA_dda_top12.raw | Human | In vitro | Blood | suspension | Chronic lymphocytic leukemia | class I | HLA-A01:01,HLA-A02:01,HLA-B07:02,HLA-B08:01,HLA-C07:01,HLA-C07:02 | 35675780 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | HPLC | no | DDA | HCD | 4 | |||||
| SYSMHC00064 | SYSMHC00064_CLL_DFCI-5283 | G20141113_JGA_3rdCML_HLA_combinedIP_hybridmethod.raw | Human | In vitro | Blood | suspension | Chronic lymphocytic leukemia | class I | HLA-A01:01,HLA-A02:01,HLA-B07:02,HLA-B08:01,HLA-C07:01,HLA-C07:02 | 35675780 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | HPLC | no | DDA | HCD | 5 |